Healthcare and life sciences innovation platform Global HealthX (GHX) has surpassed $15 million in cumulative investments across healthcare startups and studio-built ventures over the past two years.
The Hyderabad-based organisation operates under the Global University Foundation (GUF) and focuses on building scalable solutions at the intersection of healthcare, life sciences, and technology.
Global HealthX follows an integrated model that combines a venture studio, strategic investments, and market-access partnerships. Through this approach, the platform aims to address long-standing challenges in India’s healthcare system, particularly around access, affordability, and continuity of care.
Led by Dr. Ravindranath Kancherla, founder of Global Hospitals and chairman of Laurus Labs, Global HealthX functions as the innovation and R&D arm of the Global Institute for Research & Innovation (GIRI).
The organisation works closely with clinicians, researchers, and entrepreneurs to translate research into commercially viable healthcare solutions.
The latest GHX cohort features five startups working across diverse healthcare segments. These include TapHealth in AI-led chronic care, Wellytics in emergency response systems, Monitra Health in cardiac monitoring, Merry Health in genomics-driven precision medicine, and Avika, which focuses on VR-based mental health therapy.
Typically, GHX invests $250,000 to $500,000 per startup, with the ability to participate in follow-on rounds from pre-seed to Series A and beyond, depending on a company’s scale and impact potential.
Over the next year, the platform plans to deploy an additional $8–10 million in 2026, backing around 10 new startups across healthcare and life sciences.
Beyond investments, GHX actively supports founders through venture building and acceleration. Its venture studio co-creates companies from the research stage, while its accelerator programme helps both Indian and global startups localise, validate, and scale within the Indian healthcare market.
